Abstract:Cognitive dysfunction is a common symptom in Parkinson’s disease (PD). Serotonin4 (5-HT4) receptors are richly expressed in the dorsal hippocampus (dHIPP) and play an important role in cognitive activities. However, the mechanism underlying the role of dHIPP 5-HT4 receptors in PD-related cognitive dysfunction remains unclear. Here we found that unilateral 6-hydroxydopamine lesions of the medial forebrain bundle increased the protein expression of 5-HT4 receptors in the dHIPP, decreased hippocampal theta rhythm, and impaired working memory and hippocampus-dependent memory in the T-maze and hole-board test, respectively. Both activation and blockade of dHIPP 5-HT4 receptors (agonist BIMU8 and antagonist GR113808) improved working memory and hippocampus-dependent memory in the lesioned rats, but not in sham rats. Activation of dHIPP 5-HT4 receptors increased hippocampal theta rhythm in the lesioned rats. The neurochemical studies showed that injection of BIMU8, GR113808 or GR113808/BIMU8 in the dHIPP increased the levels of dopamine in the medial prefrontal cortex (mPFC), dHIPP and amygdala, and the level of 5-HT in the amygdala in the lesioned rats, but not in sham rats. Injection of GR113808 or GR113808/BIMU8 into the dHIPP also increased the levels of noradrenaline in the mPFC, dHIPP and amygdala only in the lesioned rats. These results suggest that activation or blockade of dHIPP 5-HT4 receptors may improve the cognitive impairments in parkinsonian rats, which may be due to the increase of hippocampal theta rhythm, up-regulated expressions of 5-HT4 receptors in the dHIPP and the changes in the levels of monoamines in the relative brain areas.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of Parkinson's disease (PD) - related cognitive dysfunction and its potential treatment methods. Specifically, the research focuses on the role of serotonin type 4 receptor (5 - HT_4 receptor) in the dorsal hippocampus (dHIPP) in PD - related cognitive dysfunction. Through the experimental model of rats with unilateral 6 - hydroxydopamine (6 - OHDA) lesions, the researchers explored whether the activation or blockade of 5 - HT_4 receptor in dHIPP can improve working memory and hippocampus - dependent memory, as well as the possible mechanisms behind these effects, including the changes in hippocampal theta rhythm and the regulation of monoamine levels. The main objectives of the study include: 1. To observe the changes in the expression of 5 - HT_4 receptor in dHIPP; 2. To study the effects of the activation or blockade of 5 - HT_4 receptor in dHIPP on working memory and hippocampus - dependent memory, and the relationship between these effects and the changes in hippocampal theta rhythm; 3. To investigate how the activation or blockade of 5 - HT_4 receptor in dHIPP affects the levels of monoamine substances in the limbic system and limbic - related brain regions. Through these studies, the author hopes to reveal the potential therapeutic value of 5 - HT_4 receptor in PD - related cognitive dysfunction.

Activation and blockade of 5-HT4 receptors in the dorsal hippocampus enhance working and hippocampus-dependent memories in the unilateral 6-hydroxydopamine lesioned rats